Development of electronic product information (ePI) for EU human medicines, compliant with a harmonised EU ePI Common Standard, is ongoing by the European Medicines Regulatory Network (EMRN) in collaboration with stakeholders. In the coming years, ePI will be created and updated for EU medicines as part of routine regulatory procedures.

This reflection paper calls on stakeholders to take action and invest in the development of such initiative at EU level, building on and complementing existing work to implement ePI in Europe. Opportunities, limitations and other relevant considerations are outlined. In addition, some existing EU and international examples are described.

Harmonised EU-wide linking from the medicines package to ePI of EU medicines, irrespective of the marketing authorisation holder, will require cross-stakeholder collaboration to achieve development, integration and maintenance of several components, which are described in the paper.

EMA is accepting feedback on the draft until 30 June 2025.

Source:

EMA: Reflection paper on linking to electronic product information (ePI) from EU medicine packages

Meet the GMP Compliance Adviser.

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.

The demo access is non-binding and ends automatically.

>>> Test it now for free